TY - JOUR
T1 - Drug-preloadable methacrylated gelatin microspheres fabricated using an aqueous two-phase system
AU - Mizukami, Yuya
AU - Yamaguchi, Takuma
AU - Shiono, Miki
AU - Takahashi, Yuki
AU - Shimizu, Kazunori
AU - Konishi, Satoshi
AU - Takakura, Yoshinobu
AU - Nishikawa, Makiya
N1 - Funding Information:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/12/5
Y1 - 2022/12/5
N2 - Gelatin microspheres (GMS) can retain biomolecules and be incorporated into artificial tissues and organs for tissue regeneration. However, the inactivation of biomolecules during the conventional fabrication process of GMS requires postloading of biomolecules to prefabricated GMS. Herein, a novel method for fabricating drug-preloaded GMS using a water-in-water (w/w) emulsification technique, is reported. A highly concentrated gelatin methacrylate (Gm) solution containing fibroblast growth factor 2 (FGF2), a model drug, was emulsified in a highly concentrated polyethylene glycol solution, and the mixture was irradiated with ultraviolet light. The obtained water-in-water gelatin methacrylate microspheres (w/w GmMS) were superior to conventional GMS in terms of stability, FGF2-loading efficiency, and sustained release of FGF2. The FGF2-loaded w/w GmMS efficiently activated the proliferation of adipose tissue-derived mesenchymal stem cells (ASCs). In addition, FGF2-loaded w/w GmMS incorporated into multicellular spheroids of ASCs increased the viability of ASCs in the spheroids. The therapeutic efficacy of ASC spheroids in a wound healing mouse model was significantly improved by the incorporation of FGF2-loaded w/w GmMS. These results indicate that drug-preloadable w/w GmMS can be widely applied in tissue engineering and regenerative medicine strategies.
AB - Gelatin microspheres (GMS) can retain biomolecules and be incorporated into artificial tissues and organs for tissue regeneration. However, the inactivation of biomolecules during the conventional fabrication process of GMS requires postloading of biomolecules to prefabricated GMS. Herein, a novel method for fabricating drug-preloaded GMS using a water-in-water (w/w) emulsification technique, is reported. A highly concentrated gelatin methacrylate (Gm) solution containing fibroblast growth factor 2 (FGF2), a model drug, was emulsified in a highly concentrated polyethylene glycol solution, and the mixture was irradiated with ultraviolet light. The obtained water-in-water gelatin methacrylate microspheres (w/w GmMS) were superior to conventional GMS in terms of stability, FGF2-loading efficiency, and sustained release of FGF2. The FGF2-loaded w/w GmMS efficiently activated the proliferation of adipose tissue-derived mesenchymal stem cells (ASCs). In addition, FGF2-loaded w/w GmMS incorporated into multicellular spheroids of ASCs increased the viability of ASCs in the spheroids. The therapeutic efficacy of ASC spheroids in a wound healing mouse model was significantly improved by the incorporation of FGF2-loaded w/w GmMS. These results indicate that drug-preloadable w/w GmMS can be widely applied in tissue engineering and regenerative medicine strategies.
KW - Aqueous two-phase system
KW - Gelatin methacrylate
KW - Gelatin microsphere
KW - Multicellular spheroid
UR - https://www.scopus.com/pages/publications/85141323300
U2 - 10.1016/j.eurpolymj.2022.111671
DO - 10.1016/j.eurpolymj.2022.111671
M3 - Article
AN - SCOPUS:85141323300
SN - 0014-3057
VL - 181
JO - European Polymer Journal
JF - European Polymer Journal
M1 - 111671
ER -